Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

UARK 98-035, A Phase III Study of D.T. PACE Versus High Dose Melphalan and Autologous Transplant in Patients With Previously Treated Multiple Myeloma

NCT00083876 is registered in ClinicalTrials.gov with University of Arkansas as lead sponsor.

NCT NCT00083876
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00083876 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
UARK 98-035, A Phase III Study of D.T. PACE Versus High Dose Melphalan and Autologous Transplant in Patients With Previously Treated Multiple Myeloma
Lead sponsor
University of Arkansas
Phase
Phase 3
Overall status
Completed
Start date
September 30, 1998
Completion date
November 30, 2007
Enrollment
500
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma